These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

93 related items for PubMed ID: 12223999

  • 1. Evaluation and clinical application of a new method for measuring activity of von Willebrand factor-cleaving metalloprotease (ADAMTS13).
    Böhm M, Vigh T, Scharrer I.
    Ann Hematol; 2002 Aug; 81(8):430-5. PubMed ID: 12223999
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Novel, semi-automated, 60-min-assay to determine von Willebrand factor cleaving activity of ADAMTS-13.
    Kostousov V, Fehr J, Bombeli T.
    Thromb Res; 2006 Aug; 118(6):723-31. PubMed ID: 16430944
    [Abstract] [Full Text] [Related]

  • 4. Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura.
    Tsai HM, Lian EC.
    N Engl J Med; 1998 Nov 26; 339(22):1585-94. PubMed ID: 9828246
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Thrombotic thrombocytopenic purpura and the hemolytic uremic syndrome.
    Moake JL.
    Arch Pathol Lab Med; 2002 Nov 26; 126(11):1430-3. PubMed ID: 12421153
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Acquired deficiency of von Willebrand factor-cleaving protease in a patient with thrombotic thrombocytopenic purpura.
    Furlan M, Robles R, Solenthaler M, Lämmle B.
    Blood; 1998 Apr 15; 91(8):2839-46. PubMed ID: 9531594
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Simplified assay for VWF cleaving protease (ADAMTS13) activity and inhibitor in plasma.
    Knovich MA, Craver K, Matulis MD, Lawson H, Owen J.
    Am J Hematol; 2004 Jul 15; 76(3):286-90. PubMed ID: 15224369
    [Abstract] [Full Text] [Related]

  • 16. Von Willebrand factor--cleaving protease activity in congenital thrombotic thrombocytopenic purpura.
    Allford SL, Harrison P, Lawrie AS, Liesner R, MacKie IJ, Machin SJ.
    Br J Haematol; 2000 Dec 15; 111(4):1215-22. PubMed ID: 11167764
    [Abstract] [Full Text] [Related]

  • 17. [Measurement of plasma von Willebrand factor cleaving protease in patients with varied thrombotic microangiopathy].
    Katagiri H, Kawai Y, Sugizaki N, Sakai K, Handa M, Okamoto S, Watanabe K.
    Rinsho Byori; 2003 Jun 15; 51(6):516-21. PubMed ID: 12884737
    [Abstract] [Full Text] [Related]

  • 18. Measurement of von Willebrand factor-cleaving protease (ADAMTS-13) activity in plasma: a multicenter comparison of different assay methods.
    Studt JD, Böhm M, Budde U, Girma JP, Varadi K, Lämmle B.
    J Thromb Haemost; 2003 Sep 15; 1(9):1882-7. PubMed ID: 12941027
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Platelet reactive conformation and multimeric pattern of von Willebrand factor in acquired thrombotic thrombocytopenic purpura during acute disease and remission.
    Lotta LA, Lombardi R, Mariani M, Lancellotti S, De Cristofaro R, Hollestelle MJ, Canciani MT, Mannucci PM, Peyvandi F.
    J Thromb Haemost; 2011 Sep 15; 9(9):1744-51. PubMed ID: 21726405
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.